In summary, lymphoma patients treated with B-cell depleting therapies, who were able to mount a vaccine-induced T cell response exhibited a decreased frequency of regulatory cells and an increased frequency of Th1 and CD8 + EMRA cells within the antigens-specific memory T cells compartment. Here, CD8A is linked to lymphoma.